WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Related articles:
Related suggestion:
'Challengers' review: Prepare to get hot and botheredTensions simmer near a shoal both China and the Philippines claim — Radio Free AsiaMigrant boat which capsized with 110 onSuspected 'dineParis mayor is confident that water quality will allow Olympic swimming in the River SeineParis main airport unveils new baggage handling system ahead of the 2024 OlympicsAthens skies turn an orange hue with dust clouds from North AfricaBereaved families paid a record £7.5bn inheritance tax last yearBritain's Kensington Palace releases image of Prince Louis to mark his 6th birthdayWoman charged with murder in crash that killed young brother and sister at birthday party
2.9724s , 6498.1328125 kb
Copyright © 2024 Powered by New strategy to attack aggressive brain cancer shows promise ,Earthly Essence news portal